Anderson Benjamin M, Wilson Daisy V, Qasim Muhammad, Correa Gonzalo, Evison Felicity, Gallier Suzy, Ferro Charles J, Jackson Thomas A, Sharif Adnan
Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Int J Nephrol. 2023 Jun 17;2023:5885059. doi: 10.1155/2023/5885059. eCollection 2023.
There has been little exploration of the interplay between sarcopenia and frailty in haemodialysis, particularly regarding gender difference. We aimed to (1) assess whether ultrasound-derived low muscle mass (LMM) and sarcopenia are more common in male or female haemodialysis recipients; (2) assess whether age influences any observed gender difference, and (3) explore the interplay between sarcopenia, frailty, and gender in haemodialysis recipients.
This was an exploratory analysis of a subgroup of adult prevalent (≥3 months) haemodialysis with frailty phenotype (FP) scores. Bilateral anterior thigh thickness (BATT) was obtained according to an established ultrasound protocol. Associations with frailty were explored via both linear and logistic regressions for BATT, LMM, and sarcopenia with a priori covariables, stratified by gender.
In total of 223 studies, participants had ultrasound measurements. Males showed greater prevalence of LMM. On adjusted analyses, LMM was associated with lower hand grip strength in males ( = -4.17; 95% C.I. -7.57 to -0.77; =0.02), but not females ( = -1.88; 95% C.I. -5.41 to 1.64; =0.29). LMM was also associated with slower walking speed in both males ( = -0.115; 95% C.I. -0.258 to -0.013; =0.03) and females ( = -0.152; 95% C.I. -0.300 to -0.005; =0.04). Sarcopenia was associated with greater odds of frailty on adjusted models in males (OR = 9.86; 95% C.I. 1.8 to 54.0; =0.01), but not females (OR = 5.16; 95% C.I. 0.22 to 124; =0.31).
The clinical expression and significance of sarcopenia differ substantially between males and females on haemodialysis. Further work is required to elucidate underlying mechanisms and guide tailored treatment.
关于血液透析中肌肉减少症与衰弱之间的相互作用,尤其是性别差异方面,目前鲜有研究。我们旨在:(1)评估超声检测得出的低肌肉量(LMM)和肌肉减少症在男性或女性血液透析患者中是否更常见;(2)评估年龄是否会影响观察到的性别差异;(3)探究血液透析患者中肌肉减少症、衰弱和性别的相互作用。
这是一项对具有衰弱表型(FP)评分的成年长期(≥3个月)血液透析亚组进行的探索性分析。根据既定的超声方案测量双侧大腿前侧厚度(BATT)。通过线性回归和逻辑回归,对BATT、LMM和肌肉减少症与先验协变量之间的关联进行探索,并按性别分层。
总共223项研究纳入了有超声测量数据的参与者。男性的LMM患病率更高。在调整分析中,LMM与男性较低的握力相关(β = -4.17;95%置信区间 -7.57至 -0.77;P = 0.02),但与女性无关(β = -1.88;95%置信区间 -5.41至1.64;P = 0.29)。LMM还与男性(β = -0.115;95%置信区间 -0.258至 -0.013;P = 0.03)和女性(β = -0.152;95%置信区间 -0.300至 -0.005;P = 0.04)较慢的步行速度相关。在调整模型中,肌肉减少症与男性更高的衰弱几率相关(OR = 9.86;95%置信区间1.8至54.0;P = 0.01),但与女性无关(OR = 5.16;95%置信区间0.22至124;P = 0.31)。
血液透析男性和女性中肌肉减少症的临床表型和意义存在显著差异。需要进一步研究以阐明潜在机制并指导针对性治疗。